←Back to structures
HQ683709.1__ADZ31573.1__PaVLD_ORF066R__00066
Bact-VirHQ683709.1__ADZ31573.1__PaVLD_ORF066R__00066
Identity
- Accession:
- HQ683709 ↗
- Kingdom:
- phage
Quality
90.8
mean pLDDT
Cluster
View cluster (3 members)3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 56-169
Domain cluster:
rep: MG752970.1__AVH85265.1__RsoM2USA_337__00337__D55-182
CATH (27)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3u0jA00 | 3.90.176.10 | Alpha Beta › Alpha-Beta Complex › Toxin ADP-ribosyltransferase; Chain A, domain 1 › Toxin ADP-ribosyltransferase; Chain A, domain 1 | 0.83 | 74.0 | 5.68e-01 | 100.0% | 46.1% |
| 4xzjA01 | 3.90.176.10 | Alpha Beta › Alpha-Beta Complex › Toxin ADP-ribosyltransferase; Chain A, domain 1 › Toxin ADP-ribosyltransferase; Chain A, domain 1 | 0.82 | 74.0 | 5.87e-01 | 100.0% | 51.7% |
| 6k93A00 | 3.90.176.10 | Alpha Beta › Alpha-Beta Complex › Toxin ADP-ribosyltransferase; Chain A, domain 1 › Toxin ADP-ribosyltransferase; Chain A, domain 1 | 0.80 | 66.0 | 5.09e-01 | 100.0% | 41.8% |
| 4h03A02 | 3.90.176.10 | Alpha Beta › Alpha-Beta Complex › Toxin ADP-ribosyltransferase; Chain A, domain 1 › Toxin ADP-ribosyltransferase; Chain A, domain 1 | 0.77 | 73.0 | 5.85e-01 | 100.0% | 61.9% |
| 1gzeA00 | 3.90.176.10 | Alpha Beta › Alpha-Beta Complex › Toxin ADP-ribosyltransferase; Chain A, domain 1 › Toxin ADP-ribosyltransferase; Chain A, domain 1 | 0.76 | 72.0 | 5.77e-01 | 100.0% | 60.4% |
| 4fk7A00 | 3.90.176.10 | Alpha Beta › Alpha-Beta Complex › Toxin ADP-ribosyltransferase; Chain A, domain 1 › Toxin ADP-ribosyltransferase; Chain A, domain 1 | 0.76 | 71.0 | 5.79e-01 | 100.0% | 64.0% |
| 1qs1A02 | 3.90.176.10 | Alpha Beta › Alpha-Beta Complex › Toxin ADP-ribosyltransferase; Chain A, domain 1 › Toxin ADP-ribosyltransferase; Chain A, domain 1 | 0.76 | 72.0 | 5.87e-01 | 100.0% | 60.9% |
| 2j3vA02 | 3.90.176.10 | Alpha Beta › Alpha-Beta Complex › Toxin ADP-ribosyltransferase; Chain A, domain 1 › Toxin ADP-ribosyltransferase; Chain A, domain 1 | 0.76 | 72.0 | 5.69e-01 | 100.0% | 64.2% |
| 4xsgB00 | 3.90.176.10 | Alpha Beta › Alpha-Beta Complex › Toxin ADP-ribosyltransferase; Chain A, domain 1 › Toxin ADP-ribosyltransferase; Chain A, domain 1 | 0.75 | 71.0 | 5.69e-01 | 100.0% | 63.9% |
| 1ojqA00 | 3.90.176.10 | Alpha Beta › Alpha-Beta Complex › Toxin ADP-ribosyltransferase; Chain A, domain 1 › Toxin ADP-ribosyltransferase; Chain A, domain 1 | 0.75 | 70.0 | 5.59e-01 | 100.0% | 63.2% |
| 2gwlA00 | 3.90.176.10 | Alpha Beta › Alpha-Beta Complex › Toxin ADP-ribosyltransferase; Chain A, domain 1 › Toxin ADP-ribosyltransferase; Chain A, domain 1 | 0.74 | 70.0 | 5.65e-01 | 100.0% | 63.0% |
| 1qs1A01 | 3.90.176.10 | Alpha Beta › Alpha-Beta Complex › Toxin ADP-ribosyltransferase; Chain A, domain 1 › Toxin ADP-ribosyltransferase; Chain A, domain 1 | 0.73 | 69.0 | 5.54e-01 | 100.0% | 61.6% |
| 1yqyA01 | 3.90.176.10 | Alpha Beta › Alpha-Beta Complex › Toxin ADP-ribosyltransferase; Chain A, domain 1 › Toxin ADP-ribosyltransferase; Chain A, domain 1 | 0.70 | 66.0 | 5.29e-01 | 100.0% | 60.8% |
| 2j3xA01 | 3.90.176.10 | Alpha Beta › Alpha-Beta Complex › Toxin ADP-ribosyltransferase; Chain A, domain 1 › Toxin ADP-ribosyltransferase; Chain A, domain 1 | 0.70 | 65.0 | 5.17e-01 | 100.0% | 56.4% |
| 5wtzA01 | 3.90.176.10 | Alpha Beta › Alpha-Beta Complex › Toxin ADP-ribosyltransferase; Chain A, domain 1 › Toxin ADP-ribosyltransferase; Chain A, domain 1 | 0.70 | 65.0 | 5.19e-01 | 100.0% | 58.2% |
| 3tssA02 | 2.40.50.110 | Mainly Beta › Beta Barrel › OB fold (Dihydrolipoamide Acetyltransferase, E2P) › | 0.69 | 36.0 | 4.49e-01 | 99.1% | 81.7% |
| 2wn5A01 | 3.90.176.10 | Alpha Beta › Alpha-Beta Complex › Toxin ADP-ribosyltransferase; Chain A, domain 1 › Toxin ADP-ribosyltransferase; Chain A, domain 1 | 0.68 | 63.0 | 5.24e-01 | 100.0% | 63.4% |
| 2j4xA02 | 2.40.50.110 | Mainly Beta › Beta Barrel › OB fold (Dihydrolipoamide Acetyltransferase, E2P) › | 0.65 | 37.0 | 4.56e-01 | 77.2% | 88.9% |
| 3go5A03 | 2.40.50.140 | Mainly Beta › Beta Barrel › OB fold (Dihydrolipoamide Acetyltransferase, E2P) › Nucleic acid-binding proteins | 0.61 | 34.0 | 4.21e-01 | 78.1% | 88.6% |
| 1hh2P02 | 2.40.50.140 | Mainly Beta › Beta Barrel › OB fold (Dihydrolipoamide Acetyltransferase, E2P) › Nucleic acid-binding proteins | 0.60 | 33.0 | 4.34e-01 | 77.2% | 100.0% |
| 2d3aA01 | 3.10.20.70 | Alpha Beta › Roll › Ubiquitin-like (UB roll) › Glutamine synthetase, N-terminal domain | 0.59 | 35.0 | 3.74e-01 | 100.0% | 66.3% |
| 2asbA01 | 2.40.50.140 | Mainly Beta › Beta Barrel › OB fold (Dihydrolipoamide Acetyltransferase, E2P) › Nucleic acid-binding proteins | 0.59 | 38.0 | 4.62e-01 | 83.3% | 100.0% |
| 2cqoA01 | 2.40.50.140 | Mainly Beta › Beta Barrel › OB fold (Dihydrolipoamide Acetyltransferase, E2P) › Nucleic acid-binding proteins | 0.58 | 40.0 | 4.42e-01 | 88.6% | 87.0% |
| 5lm7A02 | 2.40.50.140 | Mainly Beta › Beta Barrel › OB fold (Dihydrolipoamide Acetyltransferase, E2P) › Nucleic acid-binding proteins | 0.58 | 38.0 | 4.40e-01 | 88.6% | 97.4% |
| 4c3iG02 | 2.40.50.1060 | Mainly Beta › Beta Barrel › OB fold (Dihydrolipoamide Acetyltransferase, E2P) › | 0.54 | 38.0 | 3.56e-01 | 79.8% | 58.3% |
| 2c35B02 | 2.40.50.140 | Mainly Beta › Beta Barrel › OB fold (Dihydrolipoamide Acetyltransferase, E2P) › Nucleic acid-binding proteins | 0.53 | 37.0 | 4.08e-01 | 78.9% | 91.2% |
| 1y14D02 | 2.40.50.140 | Mainly Beta › Beta Barrel › OB fold (Dihydrolipoamide Acetyltransferase, E2P) › Nucleic acid-binding proteins | 0.52 | 35.0 | 3.92e-01 | 78.1% | 90.8% |
ECOD (47)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 2410012 | 237.1.1.2 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ART | 0.88 | 70.0 | 5.82e-01 | 100.0% | 50.8% |
| 3280971 | 237.1.1.8 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ADPrib_exo_Tox | 0.88 | 71.0 | 6.23e-01 | 100.0% | 60.4% |
| 4157545 | 237.1.1.8 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ADPrib_exo_Tox | 0.87 | 74.0 | 6.66e-01 | 100.0% | 68.0% |
| 3886084 | 237.1.1.2 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ART | 0.84 | 72.0 | 5.64e-01 | 100.0% | 45.8% |
| 1687631 | 237.1.1.8 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ADPrib_exo_Tox | 0.82 | 74.0 | 5.78e-01 | 100.0% | 49.3% |
| 4424922 | 237.1.1.34 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ART, ADPrib_exo_Tox | 0.81 | 67.0 | 5.21e-01 | 100.0% | 43.4% |
| 2547952 | 237.1.1.34 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ART, ADPrib_exo_Tox | 0.80 | 66.0 | 5.09e-01 | 100.0% | 41.8% |
| 3847347 | 237.1.1.2 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ART | 0.79 | 67.0 | 5.18e-01 | 100.0% | 43.9% |
| 3561821 | 237.1.1.2 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ART | 0.79 | 67.0 | 5.12e-01 | 100.0% | 42.0% |
| 4626477 | 237.1.1.8 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ADPrib_exo_Tox | 0.78 | 65.0 | 5.63e-01 | 100.0% | 58.8% |
| 7440 | 237.1.1.8 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ADPrib_exo_Tox | 0.76 | 72.0 | 5.87e-01 | 100.0% | 60.9% |
| 1893388 | 237.1.1.8 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ADPrib_exo_Tox | 0.76 | 72.0 | 5.72e-01 | 100.0% | 62.2% |
| 157262 | 237.1.1.8 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ADPrib_exo_Tox | 0.76 | 71.0 | 5.72e-01 | 100.0% | 60.1% |
| 308103 | 237.1.1.8 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ADPrib_exo_Tox | 0.76 | 72.0 | 5.67e-01 | 100.0% | 63.6% |
| 3612144 | 237.1.1.0 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation | 0.75 | 71.0 | 4.86e-01 | 100.0% | 34.1% |
| 1562728 | 237.1.1.8 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ADPrib_exo_Tox | 0.75 | 71.0 | 5.69e-01 | 100.0% | 63.9% |
| 4277383 | 237.1.1.8 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ADPrib_exo_Tox | 0.75 | 70.0 | 5.48e-01 | 100.0% | 59.1% |
| 3714758 | 237.1.1.0 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation | 0.75 | 70.0 | 5.36e-01 | 100.0% | 49.4% |
| 7442 | 237.1.1.8 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ADPrib_exo_Tox | 0.75 | 70.0 | 5.59e-01 | 100.0% | 63.2% |
| 4563308 | 237.1.1.8 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ADPrib_exo_Tox | 0.74 | 70.0 | 5.57e-01 | 100.0% | 60.6% |
| 7439 | 237.1.1.8 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ADPrib_exo_Tox | 0.73 | 69.0 | 5.52e-01 | 100.0% | 61.0% |
| 308110 | 237.1.1.8 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ADPrib_exo_Tox | 0.71 | 66.0 | 5.25e-01 | 100.0% | 56.5% |
| 4667235 | 2.1.1.18 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein › TRAM | 0.71 | 44.0 | 5.32e-01 | 88.6% | 94.7% |
| 4228956 | 2.1.1.0 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein | 0.70 | 39.0 | 5.10e-01 | 79.8% | 96.9% |
| 2034328 | 237.1.1.8 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ADPrib_exo_Tox | 0.70 | 65.0 | 5.21e-01 | 100.0% | 58.8% |
| 4294371 | 237.1.1.14 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › Anthrax-tox_M | 0.70 | 65.0 | 4.74e-01 | 100.0% | 42.8% |
| 2770556 | 237.1.1.8 ↗ | a+b complex topology › ADP-ribosylation › ADP-ribosylation › ADP-ribosylation › ADPrib_exo_Tox | 0.68 | 63.0 | 5.07e-01 | 100.0% | 58.2% |
| 3938105 | 2.1.1.253 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein › PF29478 | 0.66 | 39.0 | 4.79e-01 | 86.8% | 95.7% |
| 3624905 | 2.1.1.253 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein › PF29478 | 0.64 | 38.0 | 4.78e-01 | 85.1% | 98.6% |
| 3226474 | 2.1.1.253 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein › PF29478 | 0.64 | 39.0 | 4.77e-01 | 86.0% | 94.7% |
| 3413155 | 2.1.1.0 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein | 0.63 | 41.0 | 4.92e-01 | 90.4% | 98.7% |
| 3508632 | 2.1.1.0 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein | 0.62 | 36.0 | 4.41e-01 | 79.8% | 88.0% |
| 3252916 | 2.1.1.7 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein › S1 | 0.61 | 42.0 | 4.47e-01 | 85.1% | 80.0% |
| 4097972 | 239.2.1.1 ↗ | beta barrels › Ribosomal protein L25-like › HisI-like › HisI-like › PRA-CH | 0.60 | 35.0 | 3.51e-01 | 98.2% | 56.5% |
| 4582532 | 2.1.1.0 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein | 0.60 | 40.0 | 4.67e-01 | 87.7% | 96.2% |
| 4852063 | 2.1.1.0 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein | 0.58 | 41.0 | 4.46e-01 | 80.7% | 88.5% |
| 3485633 | 2.1.1.0 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein | 0.58 | 41.0 | 4.39e-01 | 86.8% | 84.0% |
| 3847353 | 2.6.1.0 ↗ | beta barrels › OB-fold › Staphylococcal nuclease › Staphylococcal nuclease | 0.57 | 41.0 | 4.22e-01 | 89.5% | 77.3% |
| 3964508 | 2.1.1.7 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein › S1 | 0.57 | 36.0 | 4.24e-01 | 84.2% | 96.0% |
| 4017905 | 2.1.1.177 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein › S1_RRP5 | 0.56 | 41.0 | 4.64e-01 | 85.1% | 100.0% |
| 3914796 | 2.6.1.0 ↗ | beta barrels › OB-fold › Staphylococcal nuclease › Staphylococcal nuclease | 0.56 | 39.0 | 4.03e-01 | 87.7% | 75.5% |
| 3426514 | 2.1.1.7 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein › S1 | 0.55 | 40.0 | 4.27e-01 | 86.8% | 87.0% |
| 3666818 | 2.1.1.138 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein › ATG11 | 0.55 | 35.0 | 4.02e-01 | 83.3% | 92.5% |
| 3244942 | 2.1.1.246 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein › PF29071 | 0.53 | 38.0 | 4.24e-01 | 85.1% | 93.3% |
| 3593533 | 2.1.1.0 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein | 0.53 | 40.0 | 4.25e-01 | 83.3% | 92.0% |
| 3736728 | 2.1.1.37 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein › OB_NTP_bind | 0.51 | 30.0 | 3.10e-01 | 78.9% | 60.0% |
| 5041945 | 2.1.1.0 ↗ | beta barrels › OB-fold › Nucleic acid-binding protein › Nucleic acid-binding protein | 0.50 | 37.0 | 3.83e-01 | 92.1% | 83.8% |